Clarithromycin and simvastatin — GPhC CRA MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: D — clarithromycin can increase simvastatin exposure and risk of myopathy
Clarithromycin inhibits CYP3A4 and can markedly increase simvastatin concentrations. The combination increases the risk of myopathy and rhabdomyolysis, especially in an older patient with previous muscle symptoms. The prescriber should be contacted to withhold simvastatin temporarily or use a suitable alternative antibiotic. Aspirin is not the key interaction in this scenario.
Reference: BNF